Abstract

Electrochemical aptasensors have been wildly used in the detection and quantification of protein biomarkers, but their practical applications are limited by inefficient signal amplification and laborious and time-consuming probe surface-immobilization procedure. Here, we combine the homogeneous electrochemical aptasensor with the CRISPR/Cas12a strategy to overcome such limitations. The binding-induced DNA strand displacement (BIDSD) strategy is designed to transform thrombin-aptamer interaction into nucleic acid output, which further triggers the rolling circle amplification (RCA) to regulate the deoxyribonuclease activity of CRISPR/Cas12a. Based on the difference in affinity of graphene to single-stranded DNA and double-stranded DNA, this electrochemical aptasensor is free of probe surface-immobilization procedure, which greatly simplifies operation steps and facilitates its flexibility. By integrating BIDSD with two amplification strategies of RCA and CRISPR/Cas12a, this electrochemical aptasensor achieves specific and sensitive detection of thrombin with a calculated limit of detection of 1.26 fM, which provides a paradigm for the sensitive detection of protein biomarker.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.